Interest in GLP-1 medications, like Ozempic and Wegovy, which are used for weight loss, has seen a notable rise among U.S. adults in recent years, a recent study reveals.
A YouGov poll, published on Friday, indicates that at least 80% of participants have heard “a little” about these drugs, which are primarily utilized to manage type 2 diabetes and can assist with weight loss.
In March 2023, awareness stood at around 60%, but by March 2024, it had climbed to 70%. The survey also highlighted that the percentage of those who reported knowing “a lot” about these medications surged from 23% to 41% in that time frame.
However, only 36% of respondents knew someone personally who uses semaglutide. Among those familiar with users, 16% mentioned family members, 11% identified friends, and 7% said they themselves take it. Interestingly, many respondents knew individuals in multiple categories.
The data suggests that women may be more likely to know users of GLP-1 medications, with awareness figures ranging from 43% to 29%, in contrast to men.
Weight loss drugs like Wegovy, Ozempic, and Zepbound have been on the market since 2005 but are only recently being utilized for obesity treatment. These medications work by mimicking natural hormones to boost insulin release and curb appetite.
Some side effects associated with these medications can include nausea, diarrhea, vomiting, and constipation.
Currently, semaglutide is prescribed for weight loss or diabetes; however, preliminary research suggests it might also help with various other health concerns, such as addiction and neurodegenerative diseases.
A recent survey found that about a quarter of those polled expressed being “very” or “somewhat” interested in using these drugs for weight loss.
Additionally, around one-third of Americans reported either currently taking the medication or being interested in trying it. Conversely, 17% indicated they were not very interested, while 45% stated a complete lack of interest.
Another poll from September highlighted that about a quarter of U.S. adults would contemplate taking weight loss medication without prior consultation with a healthcare professional.
The YouGov study was based on an online survey conducted from May 22 to 25, encompassing 1,109 adults in the U.S., with a margin of error of 4 percentage points.
